Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of FPT-20 for the Treatment of Spermatogenesis and Semen Disorders
Sponsor: Trieu, Nguyen Thi, M.D.
Summary
This clinical study aims to evaluate the efficacy and safety of a novel, natural-derived formulation (FPT-20) in supporting spermatogenesis. The investigation focuses on the formulation's potential to reduce inflammatory processes and support tissue regeneration within the testicular lobules, seminiferous tubule epithelium, and surrounding connective tissues. Additionally, the study assesses its ability to restore Leydig and Sertoli cell functions in patients with spermatogenic failure secondary to testicular inflammation.
Official title: An Open-Label Study on the Efficacy of a New Natural Origin Product (FPT-20) in Improving Spermatogenesis and Semen Parameters in Men With Spermatogenic Failure.
Key Details
Gender
MALE
Age Range
25 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2020-10-29
Completion Date
2026-05-20
Last Updated
2026-06-08
Healthy Volunteers
Yes
Interventions
FPT-20
Participants receive FPT-20 orally at a standardized dosage of 1 tablet once daily. The intervention is administered continuously for a duration of 6 to 12 months to ensure sufficient exposure for the evaluation of therapeutic efficacy on spermatogenesis.
Locations (1)
Saigon Biopharma Company Limited
Hồ Chí Minh, Ho Chi Minh City, Vietnam